arrow
Back
M

Michael J. Morris

University of Maryland Baltimore

90H-index
865Paper Count
4.0WCitation Count
Published Papers 200
Publication Date
Association of SULT2A1 Locus With Abiraterone Clearance in the Alliance A031201: Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer
err2025-12-05
err0
errOAAI
errNorton, Nadine; Larson, Nicholas B.; Jenkins, Gregory D.; Beumer, Jan H.; Langevin, Brooke; Gobbaru, Jogarao; Morris, Michael J.; Nakamura, Yusuke; Kroetz, Deanna L.; Zhu, Hao-Jie; O'donnell, Peter H.; Lewis, Lionel D.; Hertz, Daniel L.
errShare
errSave
SPARC: The Standardised Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Analysis and Reporting Consensus: A Delphi Analysis
err2025-09-13
err0
PREAI
errKen Herrmann; Jochen Walz; Steven MacLennan; Alberto Briganti; Philip Cornford; Johannes Czernin; Matthias Eiber; Stefano Fanti; Wolfgang P. Fendler; Karim Fizazi; Andrei Gafita; Silke Gillessen; Karolien Goffin; Boris Hadaschik; Michael S. Hofman; Thomas A. Hope; Tobias Maurer; Alicia K. Morgans; Michael J. Morris; Declan G. Murphy; Daniela E. Oprea-Lager; Piet Ost; Joe M. ÓSullivan; Olivier Rouvière; Shahneen Sandhu; Oliver Sartor; Mike Machaba Sathekge; Clare Tempany; Wim Witjes; Louise Emmett; Anders S. Bjartell
errShare
errSave
Final overall survival and safety analyses of the phase 3 PSMAfore trial of [177Lu]Lu-PSMA-617 versus change of androgen receptor pathway inhibitor in taxane-naive patients with metastatic castration-resistant prostate cancer
err2025-07-17
err0
errOAAI
errK. Fizazi; K.N. Chi; N.D. Shore; K. Herrmann; J.S. de Bono; D. Castellano; J.M. Piulats; A. Fléchon; X.X. Wei; H. Mahammedi; G. Roubaud; M. Fleming; T. Haas; S. Ghebremariam; T.N. Kreisl; S. Rajagopalan; O. Sartor; M.J. Morris
errShare
errSave
Health-related quality of life, pain, and symptomatic skeletal events with [177Lu]Lu-PSMA-617 in patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): an open-label, randomised, phase 3 trial
err2025-05-26
err0
PREAI
errKarim Fizazi; Michael J Morris; Neal D Shore; Kim N Chi; Michael Crosby; Johann S de Bono; Ken Herrmann; Guilhem Roubaud; James Nagarajah; Mark Fleming; Brian Lewis; Luke Nordquist; Natalie Carnahan; Samson Ghebremariam; Marianna Hertelendi; Daniel Castellano; Oliver Sartor
errShare
errSave
Impact of Concomitant Hormone Therapy on the Diagnostic Performance of 18F-Piflufolastat PET/CT in Prostate Cancer Patients: A Sub-Group Analysis of OSPREY Cohort B
err2025-05-04
err0
errOAAI
errSaperstein, Lawrence; Rowe, Steven P.; Gorin, Michael A.; Pienta, Kenneth J.; Siegel, Barry A.; Morris, Michael J.; Baskaran, Saradha; Stambler, Nancy; DiPippo, Vincent A.; Denes, Bela S.
errShare
errSave
AR alterations inform circulating tumor DNA detection in metastatic castration resistant prostate cancer patients
err2024-12-11
err0
errOAAI
errKnutson, Todd P.; Luo, Bin; Kobilka, Anna; Lyman, Jacqueline; Guo, Siyuan; Munro, Sarah A.; Li, Yingming; Heer, Rakesh; Gaughan, Luke; Morris, Michael J.; Beltran, Himisha; Ryan, Charles J.; Antonarakis, Emmanuel S.; Armstrong, Andrew J.; Halabi, Susan; Dehm, Scott M.
errShare
errSave
Association of Declining Prostate-specific Antigen Levels with Clinical Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer Receiving [177Lu]Lu-PSMA-617 in the Phase 3 VISION Trial
err2024-12-01
err0
errOAAI
errArmstrong, Andrew J.; Sartor, Oliver; de Bono, Johann; Chi, Kim; Fizazi, Karim; Krause, Bernd J.; Herrmann, Ken; Rahbar, Kambiz; Tagawa, Scott T.; Saad, Fred; Beer, Tomasz M.; Wu, Jiwen; Mirante, Osvaldo; Morris, Michael J.
errShare
errSave
Implementing evidence-based strategies for men with biochemically recurrent and advanced prostate cancer: Consensus recommendations from the US Prostate Cancer Conference 2024
errCANCER
IF5.1
err2024-12-01
err0
PREAI
errBryce, Alan H.; Agarwal, Neeraj; Beltran, Himisha; Hussain, Maha H.; Sartor, Oliver; Shore, Neal; Antonarakis, Emmanuel S.; Armstrong, Andrew J.; Calais, Jeremie; Carducci, Michael A.; Dorff, Tanya Barauskas; Efstathiou, Jason A.; Gleave, Martin; Gomella, Leonard G.; Higano, Celestia; Hope, Thomas A.; Iagaru, Andrei; Morgans, Alicia K.; Morris, David S.; Morris, Michael J.; Petrylak, Daniel P.; Reiter, Robert E.; Rettig, Matthew B.; Ryan, Charles J.; Sellinger, Scott B.; Spratt, Daniel E.; Srinivas, Sandy; Tagawa, Scott T.; Taplin, Mary-Ellen; Yu, Evan Y.; Zhang, Tian; Mckay, Rana R.; Koo, Phillip J.; Crawford, E. David
errShare
errSave
Best Patient Care Practices for Administering PSMA-Targeted Radiopharmaceutical Therapy
err2024-10-03
err0
PREAI
errCalais, Jeremie; Morris, Michael J.; Kendi, Ayse Tuba; Kalebasty, Arash Rezazadeh; Tutrone, Ronald; Anderson, Michael J.; Sartor, Oliver
errShare
errSave
Clonal Hematopoiesis and Clinical Outcomes in Metastatic Castration-Resistant Prostate Cancer Patients Given Androgen Receptor Pathway Inhibitors (Alliance A031201)
err2024-09-18
err0
PREAI
errJensen, Jeffrey L.; Bobek, Olivia; Chan, Irenaeus C. C.; Miller, Brian C.; Hillman, David W.; Heller, Glenn; Druley, Todd; Armstrong, Andrew J.; Morris, Michael J.; Milowsky, Matthew I.; Beltran, Himisha; Bolton, Kelly L.; Coombs, Catherine C.
errShare
errSave
Haematologic impact of [177Lu]Lu-PSMA-617 versus ARPI change in patients with metastatic castration-resistant prostate cancer in PSMAfore
err2024-09-01
err0
PREAI
errChi, K. N.; Sartor, O.; Fizazi, K.; de Bono, J. S.; Shore, N. D.; Herrmann, K.; Castellano Gauna, D. E.; Piulats Rodriguez, J. M.; Flechon, A.; Wei, X. X.; Kim, H.; Schweizer, M.; Alanee, S.; Ghebremariam, S.; Hertelendi, M.; Morris, M. J.
errShare
errSave
177Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): a phase 3, randomised, controlled trial
errLANCET
IF88.5
err2024-09-01
err4
PREAI
errMorris, Michael J.; Castellano, Daniel; Herrmann, Ken; de Bono, Johann S.; Shore, Neal D.; Chi, Kim N.; Crosby, Michael; Piulats, Josep M.; Flechon, Aude; Wei, Xiao X.; Mahammedi, Hakim; Roubaud, Guilhem; Studentova, Hana; Nagarajah, James; Mellado, Begona; Montesa-Pino, Alvaro; Kpamegan, Euloge; Ghebremariam, Samson; Kreisl, Teri N.; Wilke, Celine; Lehnhoff, Katja; Sartor, Oliver; Fizazi, Karim
errShare
errSave
Enhancing nursing home quality through electronic health record implementation
err2024-08-26
err0
PREAI
errRohit Pradhan; Neeraj Dayama; Michael Morris; Kimberly Elliott; Holly Felix
errShare
errSave
Standardized template for clinical reporting of PSMA PET/CT scans
err2024-08-15
err1
errOAAI
errEsfahani, Shadi A.; Morris, Michael J.; Sartor, Oliver; Frydenberg, Mark; Fanti, Stefano; Calais, Jeremie; Vapiwala, Neha
errShare
errSave
Clinical, Imaging, and Technical Factors Associated with Successful Genomic Profiling of Bone Biopsy Tissue in Prostate Cancer
err2024-08-01
err0
PREAI
errFourat Ridouani; H. Alberto Vargas; Daniel J. Holzwanger; Heiko Schöder; Emily Waters; Elena N. Petre; Axel Martin; Jaya Satagopan; Mithat Gonen; Karen A. Autio; Yu Chen; Susan F. Slovin; Daniel C. Danila; Michael J. Morris; Howard I. Scher; Maria E. Arcila; Stephen B. Solomon; Jeremy C. Durack
errShare
errSave
Single- cell analysis of treatment- resistant prostate cancer: Implications of cell state changes for cell surface antigen- targeted therapies
err2024-07-05
err4
errOAAI
errZaidi, Samir; Park, Jooyoung; Chan, Joseph M.; Roudier, Martine P.; Zhao, Jimmy L.; Gopalan, Anuradha; Wadosky, Kristine M.; Patel, Radhika A.; Sayar, Erolcan; Karthaus, Wouter R.; Kates, D. Henry; Chaudhary, Ojasvi; Xu, Tianhao; Masilionis, Ignas; Mazutis, Linas; Chaligne, Ronan; Obradovic, Aleksandar; Linkov, Irina; Barlas, Afsar; Jungbluth, Achim A.; Rekhtman, Natasha; Silber, Joachim; Manova-Todorova, Katia; Watson, Philip A.; True, Lawrence D.; Morrissey, Colm; Scher, Howard I.; Rathkopf, Dana E.; Morris, Michael J.; Goodrich, David W.; Choi, Jungmin; Nelson, Peter S.; Haffner, Michael C.; Sawyers, Charles L.
errShare
errSave
Correlation analyses of radiographic progression-free survival with clinical and health-related quality of life outcomes in metastatic castration-resistant prostate cancer: Analysis of the phase 3 VISION trial
errCANCER
IF5.1
err2024-06-21
err1
errOAAI
errMorris, Michael J.; de Bono, Johann; Nagarajah, James; Sartor, Oliver; Wei, Xiao X.; Nordquist, Luke T.; Koshkin, Vadim S.; Chi, Kim N.; Krause, Bernd J.; Herrmann, Ken; Rahbar, Kambiz; Vickers, Adrian; Mirante, Osvaldo; Ghouse, Ray; Fizazi, Karim; Tagawa, Scott T.
errShare
errSave
Resolution Dependence of Extreme Wind Speed Projections in the Great Lakes Region
err2024-06-01
err0
PREAI
errMorris, Michael; Kushner, Paul J.; Moore, G. W. K.; Mercan, Oya
errShare
errSave